Endocrinology and Metabolism Treatment Programs

Overview

In addition to treating and studying diabetes, City of Hope's Diabetes & Metabolism Research Institute also provides care and conducts research on a variety of endocrine and metabolism disorders.

Current treatment and research efforts include:

Male and Female Sexual Dysfunction (primary and secondary)

  • Management of male and female sexual dysfunction in premature gonadal/ovarian failure patients
  • Clinical research in male sexual dysfunction in patients with cancer and diabetes


Neuroendocrine Tumors (carcinoids, pancreatic endocrine tumors, etc.)

  • These tumors present a significant challenge both at diagnosis and in treatment. Research efforts include:
  • Advancing the management of neuroendocrine tumors with the use of radioactive iodine MIBG


Non-Endocrine Cancers

  • Investigation of endocrine complications as a result of chemotherapy, radiation therapy and bone marrow transplant in cancer patients.
  • Management of immunosuppressive therapy-related endocrine complications.
  • Development of clinical practice guidelines for the management of hypothalamic-pituitary endocrine complications after bone marrow transplant.
  • Aggressive prevention and treatment of bone marrow transplant osteoporosis in both men and women.


Thyroid Cancer

  • After thyroid cancer surgery, standard treatment consists of radioiodine to ablate residual tumor cells.  However, we have been exploring methods of augmenting or supplanting this therapy. Initiatives include:
  • Continued clinical research in thyroid cancer exploring new diagnostic and therapeutic alternatives to radioactive iodine therapy
  • Providing compassionate use of recombinant human thyroid stimulating hormone (Thyrogen) for thyroid cancer therapy
Back To Top